// App-Quantinova.ai

e22037 : Heterogeneity of circulating tumor cells in primary breast cancer patients.

Researchers

Presenter

  • Branislav Bystricky

Principal Investigators

  • Marian Karaba

  • Michal Konecny

  • Daniel Pindak

  • Jozef Sufliarsky

  • Jozef Mardiak

  • Michal Mego

  • Juraj Benca

  • Ludmila Vavrova

  • Jan Markus

Medical Centers

  • University Hospital Trencin, Trencin, Slovakia

  • Second Department of Oncology, Faculty of Medicine, Comenius University in Bratislava and National Cancer Institute, Bratislava, SlovakiaDept. Genetics, St Elisabeth Oncology Inst., Bratislava, SlovakiaDepartment of Clinical Oncology, National Cancer Institute, Bratislava, Slovakia

  • 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia

  • National Cancer Institute, Bratislava, Slovakia

Locations

  • Slovakia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Aldehyde dehydrogenase 1

  • Cancer antigen 15-3

  • Circulating tumor cells

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved